| 3.34 Delayed Data As of 3:26pm ET |  +0.03 / +0.91%Today’s Change | 1.03 Today|||52-Week Range 4.83 | +29.46% Year-to-Date |
| Previous close | 3.31 |
| Today’s open | 3.27 |
| Day’s range | 3.25 - 3.47 |
| Volume | 401,516 |
| Average volume (3 months) | 296,026 |
| Market cap | $81.6M |
| Earnings growth (last year) | -249.68% |
| Earnings growth (this year) | +57.29% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | -40.94% |
| P/E ratio | NM |
| Price/Sales | 0.93 |
| Price/Book | 29.26 |
| Today’s change | Today’s % change | |
|---|---|---|
| --EcoGreen Internation... | 0.00 | 0.00% |
| SCPHscPharmaceuticals In... | -0.34 | -5.16% |
| FBIOFortress Biotech Inc | -0.13 | -7.18% |
| CORVCorrevio Pharma Corp | -0.05 | -2.06% |
| Next reporting date | November 5, 2019 |
| EPS forecast (this quarter) | -$0.16 |
| Annual revenue (last year) | $103.2M |
| Annual profit (last year) | -$95.2M |
| Net profit margin | -92.29% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Gregory J. Divis |
Senior VP, Chief Financial & Accounting Officer Michael F. Kanan |
Corporate headquarters Dublin, Dublin |
